Cisplatin (Cis), a key cancer chemotherapy drug, faces limitations such as dose-dependent side effects and resistance. Photobiomodulation therapy (PBMT) shows promise as an adjuvant therapy to enhance Cis efficacy and reduce side effects.
Methods:
A systematic review was conducted to evaluate the combined effects of PBMT and Cis on various cancers. After searching five databases using relevant keywords, nine studies were included, encompassing both in vitro and in vivo models.
Results:
Most in vitro studies showed a synergistic effect, with enhanced cancer cell inhibition, apoptosis induction, and reduced cell viability compared with Cis alone. The animal model confirmed these findings, showing PBMT mitigated Cis-induced acute renal failure.
Conclusion:
Mechanistically, PBMT may increase reactive oxygen species generation, cytochrome c release, modulate cellular metabolism, and involve the miR-124/STAT3 signaling pathway. Combining PBMT with Cis appears to be a safe and effective cancer treatment strategy, synergistically inhibiting cancer cell growth and reducing side effects. Further clinical trials are needed to validate these findings.
Get full access to this article
View all access options for this article.
References
1.
NazariNA, SarajarBO, AzarshinSZ, et al.Overcoming Cisplatin’s Challenges: A promising future in cancer care; a comprehensive review. Int J Med Toxicol Forensic Med, 2023; 13(4).
2.
JalaliF, FakhariF, SepehrA, et al.Synergistic anticancer effects of doxorubicin and metformin combination therapy: A systematic review. Transl Oncol, 2024; 45:101946.
3.
JafarzadehE, MontazeriV, AliebrahimiS, et al.Targeting cancer stem cells and hedgehog pathway: Enhancing cisplatin efficacy in ovarian cancer with Metformin. J Cell Mol Med, 2025 May;29(10):e70508.
4.
KarimiZ, GhazbaniA, Kashefian NaeeiniS, et al.Systematic review of fecal and mucosa-associated microbiota compositional shifts in colorectal cancer. Iran J Colorectal Res, 2020; 8(2):41–64.
5.
AbesiF, DerikvandN. Efficacy of low-level laser therapy in wound healing and pain reduction after gingivectomy: A systematic review and meta-analysis. J Lasers Med Sci, 2023; 14:e17.
6.
TamSY, TamVC, RamkumarS, et al.Review on the cellular mechanisms of low-level laser therapy use in oncology. Front Oncol, 2020; 10:1255.
7.
AliAO, NajmFMS, MuhammadZ-A, et al.Low Level Laser Therapy (LLLT) mechanism of action, application and laser light therapy devices in physical therapy. J Curr Med Res Opin, 2024; 7(06):2757–2765.
8.
MoherD, LiberatiA, TetzlaffJ, et al.; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Int J Surg, 2010; 8(5):336–341.
9.
Seragel-DeenF, GhaniSAA, BaghdadiHM, et al.Combined cisplatin treatment and photobiomodulation at high fluence induces cytochrome c release and cytomorphologic alterations in HEp-2 cells. Open Access Maced J Med Sci, 2020; 8(A):366–373.
10.
HeymannPG, MandicR, KämmererPW, et al.Laser-enhanced cytotoxicity of zoledronic acid and cisplatin on primary human fibroblasts and head and neck squamous cell carcinoma cell line UM-SCC-3. J Craniomaxillofac Surg, 2014; 42(7):1469–1474.
11.
HeymannPGB, HenkeniusKSE, ZiebartT, et al.Modulation of tumor cell metabolism by laser photochemotherapy with cisplatin or zoledronic acid in vitro. Anticancer Res, 2018; 38(3):1291–1301.
12.
DinizIM, SoutoGR, FreitasID, et al.Photobiomodulation enhances cisplatin cytotoxicity in a culture model with oral cell lineages. Photochem Photobiol, 2020; 96(1):182–190.
13.
ZafariJ, Javani JouniF, JamaliS, et al.The effect of cisplatin-low-level laser therapy on cell viability and death of LNCaP prostate cancer cell line. Lasers Med Sci, 2022; 37(2):1283–1288.
14.
HeymannPGB, ZiebartT, KämmererPW, et al.The enhancing effect of a laser photochemotherapy with cisplatin or zolendronic acid in primary human osteoblasts and osteosarcoma cells in vitro. J Oral Pathol Med, 2016; 45(10):803–809.
15.
ZafariJ, AbbasiniaH, GharehyaziH, et al.Evaluation of biological activity of different wavelengths of low-level laser therapy on the cancer prostate cell line compared with cisplatin. J Lasers Med Sci, 2021; 12:e17.
16.
UnayS, BilginMD. Investigation of effects of quercetin and low-level laser therapy in cisplatin-induced in vitro peripheral neuropathy model. Lasers Med Sci, 2023; 38(1):49.
17.
KassabKN, HassanAI, KhaterMS, et al.Evaluating the regenerative potential of low level laser and/or epidermal growth factor therapies in cisplatin induced acute renal failure in rats. Int J Med Med Sci, 2013; 46(1):1134.
18.
AldossarySA. Review on pharmacology of cisplatin: Clinical use, toxicity and mechanism of resistance of cisplatin. Biomed Pharmacol J, 2019; 12(1):7–15.
19.
ZafariJ, Rastegar-PouyaniN, Javani JouniF, et al.Static magnetic field reduces cisplatin resistance via increasing apoptosis pathways and genotoxicity in cancer cell lines. Sci Rep, 2024; 14(1):5792.
20.
LiY, XuQ, ShiM, et al.Low-level laser therapy induces human umbilical vascular endothelial cell proliferation, migration and tube formation through activating the PI3K/Akt signaling pathway. Microvasc Res, 2020; 129:103959.
21.
GaoX, XingD. Molecular mechanisms of cell proliferation induced by low power laser irradiation. J Biomed Sci, 2009; 16(1):4–16.
22.
De FreitasLF, HamblinMR. Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE J Sel Top Quantum Electron, 2016; 22(3):7000417–7000464.
23.
FarivarS, MalekshahabiT, ShiariR. Biological effects of low level laser therapy. J Lasers Med Sci, 2014; 5(2):58–62.
24.
LallaRV, BrennanMT, GordonSM, et al.Oral mucositis due to high-dose chemotherapy and/or head and neck radiation therapy. JNCI Monogr, 2019; 2019(53):lgz011.
25.
BjordalJM, BensadounR-J, TunèrJ, et al.A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis. Support Care Cancer, 2011; 19(8):1069–1077.
26.
PengL, LuoZ, LiuD, et al.LOW-Intensity ultrasound enhanced the antitumor effects of cisplatin in non-small cell lung cancer cells via inhibiting MIR-124/STAT3 Signaling. Excli J, 2018; 17.
27.
ChoiY-M, KimH-K, ShimW, et al.Mechanism of cisplatin-induced cytotoxicity is correlated to impaired metabolism due to mitochondrial ROS generation. PLoS One, 2015; 10(8):e0135083.
